Perceptive Life Sciences Master Fund Ltd

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Perceptive Life Sciences Master Fund Ltd
CIK #0001249675
EDGAR Form CIK 2011 - 2026
3 [0001249675]
4 [0001249675]
Form 3/4/5 Subject 2011 - 2026
Perceptive Life Sciences Master Fund Ltd
Kardigan Inc
Edelman Joseph
Perceptive Advisors LLC
MeiraGTx Holdings PLC
Solid Biosciences Inc
Immatics NV
LeonaBio Inc
Perceptive Xontogeny Venture Fund II LP
Perceptive LS A LLC
Lyra Therapeutics Inc
Adagio Medical Holdings Inc
Health Sciences Acquisitions Corp 2
Acrivon Therapeutics Inc
Aldeyra Therapeutics Inc
Perceptive Xontogeny Venture Fund LP
C2 Life Sciences LLC
ARYA Sciences Acquisition Corp III
ARYA Sciences Acquisition Corp II
LianBio
Catabasis Pharmaceuticals Inc
Verrica Pharmaceuticals Inc
CARGO Therapeutics Inc
Soleno Therapeutics Inc
VBI Vaccines Inc/BC
Landos Biopharma Inc
Perceptive Venture Advisors LLC
Quotient Ltd
Albireo Pharma Inc
LEV LB Holdings LP
LEV LB Holdings GP LLC
Crinetics Pharmaceuticals Inc
Agile Therapeutics Inc
PCOF EQ AIV III LP
IsoPlexis Corp
Perceptive Credit Advisors LLC
Perceptive Credit Holdings III LP
Rain Oncology Inc
ADMA Biologics Inc
Cypherpunk Technologies Inc
VYNE Therapeutics Inc
Prometheus Biosciences Inc
Xontogeny LLC
Scynexis Inc
Motus GI Holdings Inc
Kinex Pharmaceuticals LLC
Kadmon Holdings Inc
Dova Pharmaceuticals Inc
Foamix Pharmaceuticals Ltd
Amicus Therapeutics Inc
La Jolla Pharmaceutical Co
Corium International Inc
Zogenix Inc
Global Blood Therapeutics Inc
Aravive Inc
Talphera Inc
VBI Vaccines Inc
Aegerion Pharmaceuticals Inc
Repros Therapeutics Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Solid Biosciences Inc SLDB
Pre-Funded Warrant (right to buy) · derivative
2026-03-09 Grant 8,912,655 $5.61 49,999,995
MeiraGTx Holdings PLC MGTX
Ordinary Shares
2025-12-31 Disposed to issuer 2,300,000 $7.91 18,193,000
LeonaBio Inc ATHA
Series A Warrant (right to buy) · derivative
2025-12-23 Grant 1,279,526 $6.35 8,124,990
LeonaBio Inc ATHA
Common Stock
2025-12-23 Grant 329,756 $6.35 2,093,951
LeonaBio Inc ATHA
Common Stock
2025-12-23 Grant 989,270 $6.35 6,281,864
LeonaBio Inc ATHA
Pre-Funded Warrant (right to buy) · derivative
2025-12-23 Grant 1,372,935 $6.35 8,718,137
LeonaBio Inc ATHA
Series B Warrant (right to buy) · derivative
2025-12-23 Grant 1,181,101 $6.35 7,499,991
LeonaBio Inc ATHA
Series A Warrant (right to buy) · derivative
2025-12-23 Grant 3,838,583 $6.35 24,375,002
LeonaBio Inc ATHA
Series B Warrant (right to buy) · derivative
2025-12-23 Grant 3,543,307 $6.35 22,499,999
LeonaBio Inc ATHA
Pre-Funded Warrant (right to buy) · derivative
2025-12-23 Grant 5,502,402
LeonaBio Inc ATHA
Pre-Funded Warrant (right to buy) · derivative
2025-12-23 Grant 457,645 $6.35 2,906,046
Lyra Therapeutics Inc LYRA
Common Stock
2025-11-13 Sell 3,213 $3.90 12,531
Lyra Therapeutics Inc LYRA
Common Stock
2025-11-13 Sell 28,597 $3.90 111,528
Lyra Therapeutics Inc LYRA
Common Stock
2025-11-12 Sell 883 $4.06 3,585
Lyra Therapeutics Inc LYRA
Common Stock
2025-11-12 Sell 7,862 $4.06 31,920
Lyra Therapeutics Inc LYRA
Common Stock
2025-11-11 Sell 4,783 $4.31 20,615
Lyra Therapeutics Inc LYRA
Common Stock
2025-11-11 Sell 537 $4.31 2,314
Lyra Therapeutics Inc LYRA
Common Stock
2025-11-10 Sell 16,633 $4.54 75,514
Lyra Therapeutics Inc LYRA
Common Stock
2025-11-10 Sell 1,869 $4.54 8,485
Lyra Therapeutics Inc LYRA
Common Stock
2025-11-07 Sell 17,746 $4.75 84,294
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com